Measurement of immunoreactive gamma-MSH in human plasma

Clin Endocrinol (Oxf). 1984 Aug;21(2):139-48. doi: 10.1111/j.1365-2265.1984.tb03453.x.

Abstract

A radioimmunoassay for immunoreactive gamma-MSH (IR-gamma-MSH) in human plasma has been developed. The assay is capable of detecting normal basal circulating levels which range from less than 20-100 ng/1 at 0900 h. Plasma levels are raised concomitantly with ACTH during insulin induced hypoglycaemia and CRF stimulation and suppressed with dexamethasone. Chromatographic characterisation of IR-gamma-MSH in plasma demonstrates a major peak of IR-gamma-MSH, corresponding to purified glycosylated N-terminal pro-opiomelanocortin 1-76, when IR-gamma-MSH is secreted from the pituitary. In contrast IR-gamma-MSH produced ectopically appears to be heterogeneous.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ACTH Syndrome, Ectopic / blood
  • ACTH Syndrome, Ectopic / drug therapy
  • Adrenal Gland Diseases / blood
  • Adrenal Gland Diseases / drug therapy
  • Adrenocorticotropic Hormone / blood
  • Blood Glucose / metabolism
  • Circadian Rhythm
  • Corticotropin-Releasing Hormone / pharmacology
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Insulin / pharmacology
  • Male
  • Melanocyte-Stimulating Hormones / blood*
  • Nelson Syndrome / blood
  • Radioimmunoassay / methods

Substances

  • Blood Glucose
  • Insulin
  • Dexamethasone
  • Adrenocorticotropic Hormone
  • Melanocyte-Stimulating Hormones
  • Corticotropin-Releasing Hormone